Form 4 for VCYT VERACYTE, INC.
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001384101-22-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-09 | 2022-08-05 | VCYT | Chambers Rebecca | CFO | A - Grant | $0.00 | +21.4K | 76.8K | +39% | $0 |
| D | 2022-08-09 | 2022-08-05 | VCYT | Chambers Rebecca | CFO | A - Grant | $0.00 | +36.5K | 36.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | A | A | 21,404 | $0.00 | 76,756 | D | — | — | (F2) Includes 624 shares of common stock purchased on July 29, 2022 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
| 2 | Derivative | Common Stock | 2022-08-05 | A | A | 36,496 | $0.00 | 36,496 | D | $27.90 · — to 2032-08-05 | 36,496 Stock Option (right to buy) | (F3) The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. |